A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass
Publication
, Other
Bennett-Guerrero, E; Grocott, HP; Levy, JH; Stierer, KA; Hogue, CW; Cheung, AT; Newman, MF; Carter, AA; Rossignol, DP; Collard, CD
Published in: Anesthesia & Analgesia
2007
Duke Scholars
Published In
Anesthesia & Analgesia
Publication Date
2007
Volume
104
Issue
2
Start / End Page
378 / 383
Related Subject Headings
- Anesthesiology
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bennett-Guerrero, E., Grocott, H. P., Levy, J. H., Stierer, K. A., Hogue, C. W., Cheung, A. T., … Collard, C. D. (2007). A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesthesia & Analgesia.
Bennett-Guerrero, E., H. P. Grocott, J. H. Levy, K. A. Stierer, C. W. Hogue, A. T. Cheung, M. F. Newman, A. A. Carter, D. P. Rossignol, and C. D. Collard. “A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass.” Anesthesia & Analgesia, 2007.
Bennett-Guerrero E, Grocott HP, Levy JH, Stierer KA, Hogue CW, Cheung AT, et al. A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Vol. 104, Anesthesia & Analgesia. 2007. p. 378–83.
Bennett-Guerrero, E., et al. “A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass.” Anesthesia & Analgesia, vol. 104, no. 2, 2007, pp. 378–83.
Bennett-Guerrero E, Grocott HP, Levy JH, Stierer KA, Hogue CW, Cheung AT, Newman MF, Carter AA, Rossignol DP, Collard CD. A phase II double-blind placebo-controlled ascending dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesthesia & Analgesia. 2007. p. 378–383.
Published In
Anesthesia & Analgesia
Publication Date
2007
Volume
104
Issue
2
Start / End Page
378 / 383
Related Subject Headings
- Anesthesiology
- 1109 Neurosciences
- 1103 Clinical Sciences